Product Information
ANTACID EX-STR 750 MG TAB CHEW is a generic product labeled by Rugby Laboratories, priced at $0.0315 per EA under NDC 00536122922. Its NADAC has been published 350 times since Jan 22, 2020.
Strength
750 mg/1
Manufacturer
Rugby LaboratoriesNDC
00536122922
Classification
Generic
Dosage Form
TABLET, CHEWABLE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CALCIUM CARBONATEApproval Type
OTC MONOGRAPH DRUG
FDA Application
part331On Market Since
4/14/2019
Pharmacological Classes
Price Statistics
The NADAC for ANTACID EX-STR 750 MG TAB CHEW has been published 350 times since Jan 22, 2020, and over the history we have for it it has risen 28.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0315 per EA |
|---|---|
| All-time high | $0.0330 (Nov 13, 2024) |
| All-time low | $0.0242 (Jun 17, 2020) |
| 52-week high | $0.0325 |
| 52-week low | $0.0311 |
| Median price | $0.0265 |
| Average price | $0.0282 |
| Largest weekly change | -15.0% (Sep 21, 2022) |
| Weeks tracked | 350 |
| Tracking since | Jan 22, 2020 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rugby Laboratories manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Calcium carbonate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Blood Coagulation Factor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ANTACID EX-STR 750 MG TAB CHEW?
The current National Average Drug Acquisition Cost (NADAC) for ANTACID EX-STR 750 MG TAB CHEW, manufactured by Rugby Laboratories, is $0.0315 per EA (NDC 00536122922), effective Sep 30, 2026.
How has the price of ANTACID EX-STR 750 MG TAB CHEW changed over time?
Over the history we have for it, the NADAC for ANTACID EX-STR 750 MG TAB CHEW has risen 28.3%. It has been tracked across 350 weekly CMS publications since Jan 22, 2020.
What are the highest and lowest recorded NADAC prices for ANTACID EX-STR 750 MG TAB CHEW?
Since Jan 22, 2020, the NADAC for ANTACID EX-STR 750 MG TAB CHEW has ranged from a low of $0.0242 (Jun 17, 2020) to a high of $0.0330 (Nov 13, 2024), with a median of $0.0265 per EA.
Are there cheaper alternatives to ANTACID EX-STR 750 MG TAB CHEW?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ANTACID EX-STR 750 MG TAB CHEW in a comparable dosage form, but none are currently priced below it.
Who manufactures ANTACID EX-STR 750 MG TAB CHEW?
ANTACID EX-STR 750 MG TAB CHEW (NDC 00536122922) is labeled by Rugby Laboratories, and CMS classifies it as a generic product.